These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11939689)

  • 21. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    Urban C; Go E; Mariano N; Berger BJ; Avraham I; Rubin D; Rahal JJ
    J Infect Dis; 1993 Feb; 167(2):448-51. PubMed ID: 8421178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Lin HS; Lee MH; Cheng CW; Hsu PC; Leu HS; Huang CT; Ye JJ
    Infect Dis (Lond); 2015 Jun; 47(6):370-8. PubMed ID: 25746600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
    Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S
    J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
    Lee NY; Wang CL; Chuang YC; Yu WL; Lee HC; Chang CM; Wang LR; Ko WC
    Pharmacotherapy; 2007 Nov; 27(11):1506-11. PubMed ID: 17963460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of ventriculoperitoneal shunt infection and ventriculitis caused by Acinetobacter baumannii: a case report.
    Demoz GT; Alebachew M; Legesse Y; Ayalneh B
    J Med Case Rep; 2018 May; 12(1):141. PubMed ID: 29788980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.
    Wood GC; Hanes SD; Croce MA; Fabian TC; Boucher BA
    Clin Infect Dis; 2002 Jun; 34(11):1425-30. PubMed ID: 12015687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restricting the use of ampicillin-sulbactam.
    Zavascki AP; Sandri AM
    J Hosp Infect; 2004 Feb; 56(2):165-6. PubMed ID: 15019231
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
    Choi JY; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YK; Kim MS; Kim YA; Song YG; Yong D; Lee K; Kim JM
    Yonsei Med J; 2006 Feb; 47(1):63-9. PubMed ID: 16502486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.
    Lenhard JR; Smith NM; Bulman ZP; Tao X; Thamlikitkul V; Shin BS; Nation RL; Li J; Bulitta JB; Tsuji BT
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052852
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.
    Levin AS
    Clin Microbiol Infect; 2002 Mar; 8(3):144-53. PubMed ID: 12010169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampicillin/sulbactam: its potential use in treating infections in critically ill patients.
    Adnan S; Paterson DL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Nov; 42(5):384-9. PubMed ID: 24041466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of unforeseen intractable severe bacteremia due to Acinetobacter baumannii--an efficacy of sulbactam--.
    Takahashi N; Shimada T; Tanabe K; Sato M; Kitamura J; Sato H; Yoshitomi H; Ishibashi Y; Sakane T
    Jpn J Infect Dis; 2009 Nov; 62(6):461-3. PubMed ID: 19934540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.
    Reddy T; Chopra T; Marchaim D; Pogue JM; Alangaden G; Salimnia H; Boikov D; Navon-Venezia S; Akins R; Selman P; Dhar S; Kaye KS
    Antimicrob Agents Chemother; 2010 May; 54(5):2235-8. PubMed ID: 20211887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
    Khalili H; Shojaei L; Mohammadi M; Beigmohammadi MT; Abdollahi A; Doomanlou M
    J Comp Eff Res; 2018 Sep; 7(9):901-911. PubMed ID: 30192166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal use of amikacin: a case report.
    Barrou L; Charra B; Hachimi A; Idali B; Benslama A; Motaouakkil S
    Braz J Infect Dis; 2008 Dec; 12(6):546. PubMed ID: 19287849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
    Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
    J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.